Page last updated: 2024-09-05

sb 203580 and astressin

sb 203580 has been researched along with astressin in 1 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (astressin)	Trials (astressin)	Recent Studies (post-2010) (astressin)
3,489	4	1,137	170	0	36

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dow, KE; Ji, P; Nan, X; Wang, W	1

Other Studies

1 other study(ies) available for sb 203580 and astressin

Article	Year
Corticotropin releasing hormone modulates endotoxin-induced inflammatory cytokine expression in human trophoblast cells. Placenta, 2007, Volume: 28, Issue:10 Topics: Cells, Cultured; Corticotropin-Releasing Hormone; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Imidazoles; Interleukin-8; Lipopolysaccharides; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Pregnancy; Pyridines; Toll-Like Receptor 4; Trophoblasts; Tumor Necrosis Factor-alpha	2007

Article

Year

Corticotropin releasing hormone modulates endotoxin-induced inflammatory cytokine expression in human trophoblast cells.

Placenta, 2007, Volume: 28, Issue:10

Topics: Cells, Cultured; Corticotropin-Releasing Hormone; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Imidazoles; Interleukin-8; Lipopolysaccharides; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Pregnancy; Pyridines; Toll-Like Receptor 4; Trophoblasts; Tumor Necrosis Factor-alpha

2007